Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1/2 3Phase NA 1Phase 2/3 1Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 10Multiple Myeloma 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Leukemia, Lymphocytic, Chronic, B-Cell 5Leukemia 5Hodgkin Disease 5Myelodysplastic Syndromes 4Lymphoma, Non-Hodgkin 4Lymphoma, Mantle-Cell 4Lymphoma 4Hematologic Neoplasms 4Anemia, Refractory, with Excess of Blasts 4Recurrence 3Primary Myelofibrosis 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 2Lymphoma, B-Cell 2Leukemia, Prolymphocytic 2Leukemia, Plasma Cell 2Burkitt Lymphoma 2Thalassemia 1Skin Neoplasms 1Polycythemia Vera 1Peritoneal Tumor 1Pancreatic Neoplasms 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Myeloid Hematological Malignancies 1Mesothelin-positive Advanced Malignant Solid Tumors 1

Interventions

fludarabine 1Immunotherapy, Adoptive 1Diet 1Cyclophosphamide 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Leukemia, B-Cell × fludarabine × Clear all
NCT03302403 2020-10-08

Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors

First Affiliated Hospital of Wenzhou Medical University

Phase NA Unknown
18 enrolled
GastrointestinalLymphoidOther hematologic neoplasmPlasma cell

Carcinoma, Hepatocellular, Pancreatic Neoplasms, Leukemia, B-Cell, Lymphoma, B-Cell, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡